NewsRx

Search our medical news database

Breast Cancer

Xoft, Inc., Announces Additional Funding for Breakthrough Electronic Brachytherapy Technology

Published in Health Business Week, April 20th, 2007

Xoft, Inc., developer of Electronic Brachytherapy, a proprietary cancer treatment platform, announced that the company has closed a Series D round of financing, totaling $33.2 million in additional equity funding. Designed to help reduce recurrence of breast cancer, the Axxent(R) Electronic Brachytherapy System uses a miniaturized X-ray source that can deliver localized and targeted radiation treatment in virtually any clinical setting under the supervision of a radiation oncologist.

All of Xoft's current investors participated in the Series D financing, including MPM Capital, Sutter Hill Ventures, Maverick Capital, Frazier Healthcare Ventures, Mosaix Ventures, Cutlass...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook